CompaniesGenaissance Pharmaceuticals

Genaissance Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

410

By Phase

PHASE3: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2005

2006

2007

2008

Today

Hover over trial bars to see details

Recent Trials

NCT00285376Lead Sponsor

Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response

PHASE3Completed

410 participants

Started: Feb 28, 2006 · Completed: May 31, 2007

Funding History (20)

DEFA14A

Sep 28, 2005

DEFA14A

Sep 26, 2005

DEFM14A

Sep 2, 2005

8-K

Aug 16, 2005

8-K

Aug 2, 2005

8-K

Jul 21, 2005

8-K

Jun 24, 2005

8-K

Jun 21, 2005

8-K

May 3, 2005

8-K

Apr 27, 2005

Related Companies

Clinical Data

acquired